Literature DB >> 21963579

Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane.

Jeffrey Bierbrauer1, Susanne Koch, Claudio Olbricht, Jida Hamati, Dörte Lodka, Joanna Schneider, Anja Luther-Schröder, Christian Kleber, Katharina Faust, Solveigh Wiesener, Claudia D Spies, Joachim Spranger, Simone Spuler, Jens Fielitz, Steffen Weber-Carstens.   

Abstract

OBJECTIVE: Intensive care unit-acquired weakness indicates increased morbidity and mortality. Nonexcitable muscle membrane after direct muscle stimulation develops early and predicts intensive care unit-acquired weakness in sedated, mechanically ventilated patients. A comparison of muscle histology at an early stage in intensive care unit-acquired weakness has not been done. We investigated whether nonexcitable muscle membrane indicates fast-twitch myofiber atrophy during the early course of critical illness.
DESIGN: Prospective observational study.
SETTING: Two intensive care units at Charité University Medicine, Berlin. PATIENTS: Patients at increased risk for development of intensive care unit-acquired weakness, indicated by Sepsis-related Organ Failure Assessment scores ≥8 on 3 of 5 consecutive days within their first week in the intensive care unit.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Electrophysiological compound muscle action potentials after direct muscle stimulation and muscle biopsies were obtained at median days 7 and 5, respectively. Patients with nonexcitable muscle membranes (n = 15) showed smaller median type II cross-sectional areas (p < .05), whereas type I muscle fibers did not compared with patients with preserved muscle membrane excitability (compound muscle action potentials after direct muscle stimulation ≥3.0 mV; n = 9). We also observed decreased mRNA transcription levels of myosin heavy chain isoform IIa and a lower densitometric ratio of fast-to-slow myosin heavy chain protein content.
CONCLUSION: We suggest that electrophysiological nonexcitable muscle membrane predicts preferential type II fiber atrophy in intensive care unit patients during early critical illness.

Entities:  

Mesh:

Year:  2012        PMID: 21963579     DOI: 10.1097/CCM.0b013e31823295e6

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  26 in total

1.  Slow recovery of the impaired fatigue resistance in postunloading mouse soleus muscle corresponding to decreased mitochondrial function and a compensatory increase in type I slow fibers.

Authors:  Han-Zhong Feng; Xuequn Chen; Moh H Malek; J-P Jin
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-07       Impact factor: 4.249

Review 2.  [Intensive care unit acquired weakness. Pathogenesis, treatment, rehabilitation and outcome].

Authors:  M Ponfick; K Bösl; J Lüdemann-Podubecka; G Neumann; M Pohl; D A Nowak; H-J Gdynia
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

Review 3.  The ICM research agenda on intensive care unit-acquired weakness.

Authors:  Nicola Latronico; Margaret Herridge; Ramona O Hopkins; Derek Angus; Nicholas Hart; Greet Hermans; Theodore Iwashyna; Yaseen Arabi; Giuseppe Citerio; E. Wesley Ely; Jesse Hall; Sangeeta Mehta; Kathleen Puntillo; Johannes Van den Hoeven; Hannah Wunsch; Deborah Cook; Claudia Dos Santos; Gordon Rubenfeld; Jean-Louis Vincent; Greet Van den Berghe; Elie Azoulay; Dale M Needham
Journal:  Intensive Care Med       Date:  2017-03-13       Impact factor: 17.440

Review 4.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

5.  Neuromuscular junctions (NMJs): ultrastructural analysis and nicotinic acetylcholine receptor (nAChR) subunit mRNA expression in offspring subjected to protein restriction throughout pregnancy.

Authors:  Paula Aiello Tomé de Souza Castro; Ludimila Canuto Faccioni; Patrícia Aline Boer; Robson Francisco Carvalho; Selma Maria Michelin Matheus; Maeli Dal-Pai-Silva
Journal:  Int J Exp Pathol       Date:  2017-05-25       Impact factor: 1.925

Review 6.  [Critical illness polyneuropathy and critical illness myopathy].

Authors:  A Grimm; A Günther; O W Witte; H Axer
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-10-28       Impact factor: 0.840

7.  Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy.

Authors:  Claudia Langhans; Steffen Weber-Carstens; Franziska Schmidt; Jida Hamati; Melanie Kny; Xiaoxi Zhu; Tobias Wollersheim; Susanne Koch; Martin Krebs; Herbert Schulz; Doerte Lodka; Kathrin Saar; Siegfried Labeit; Claudia Spies; Norbert Hubner; Joachim Spranger; Simone Spuler; Michael Boschmann; Gunnar Dittmar; Gillian Butler-Browne; Vincent Mouly; Jens Fielitz
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

8.  The E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy.

Authors:  Franziska Schmidt; Melanie Kny; Xiaoxi Zhu; Tobias Wollersheim; Kathleen Persicke; Claudia Langhans; Doerte Lodka; Christian Kleber; Steffen Weber-Carstens; Jens Fielitz
Journal:  Crit Care       Date:  2014-09-29       Impact factor: 9.097

9.  Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness.

Authors:  Tobias Wollersheim; Janine Woehlecke; Martin Krebs; Jida Hamati; Doerte Lodka; Anja Luther-Schroeder; Claudia Langhans; Kurt Haas; Theresa Radtke; Christian Kleber; Claudia Spies; Siegfried Labeit; Markus Schuelke; Simone Spuler; Joachim Spranger; Steffen Weber-Carstens; Jens Fielitz
Journal:  Intensive Care Med       Date:  2014-02-15       Impact factor: 17.440

10.  Imaging opens possibilities both to target and to evaluate nutrition in critical illness.

Authors:  Olav Rooyackers; Jan Wernerman
Journal:  Crit Care       Date:  2014-05-21       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.